Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Luisa
Maria Luisa Bondi', Altavilla Milicia IT
| Patent application number | Description | Published |
|---|---|---|
| 20100247619 | Nanostructured Lipid Carriers Containing Riluzole And Phamaceutical Formulations Containing Said Particles - This invention relates to nanoparticles consisting of riluzole trapped in lipids, and their use to prepare medicinal products for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis. | 09-30-2010 |
Maria Luisa Calvo-Munoz, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20090115031 | SEMICONDUCTOR DEVICE INCLUDING A COUPLED DIELECTRIC LAYER AND METAL LAYER, METHOD OF FABRICATION THEREOF, AND PASSIVATING COUPLING MATERIAL COMPRISING MULTIPLE ORGANIC COMPONENTS FOR USE IN A SEMICONDUCTOR DEVICE - A material for passivating a dielectric layer in a semiconductor device has a molecular structure permitting or at least promoting liquid phase metal deposition thereon in a subsequent process step. The contemplated material may be constituted by multiple organic components. A semiconductor device including a layer of the passivating coupling material, and a method of manufacturing such a semiconductor device are also contemplated. | 05-07-2009 |
| 20100200995 | COUPLING LAYER COMPOSITION FOR A SEMICONDUCTOR DEVICE, SEMICONDUCTOR DEVICE, METHOD OF FORMING THE COUPLING LAYER, AND APPARATUS FOR THE MANUFACTURE OF A SEMICONDUCTOR DEVICE - Molecules of a coupling layer composition in a semiconductor device are bidimensionally polymerized in order to provide enhanced moisture blocking effect, particularly when the coupling layer is formed on a porous layer, such as a porous dielectric layer. The deposition of the coupling layer on the underlying structure and/or the cross-polymerization of the coupling layer composition and/or a final metallization can be photo-activated, especially, but not only, using an ultraviolet light. | 08-12-2010 |
| 20110021024 | SURFACE TREATMENT IN SEMICONDUCTOR MANUFACTURING - The present invention provides a process for forming a capping layer on a conducting interconnect for a semiconductor device, the process comprising: providing a substrate comprising one or more conductors in a dielectric layer, the conductors having an oxide layer at their surface; exposing the surface of the substrate to a vapour of β-diketone or a β-ketoimine; and depositing a capping layer on the surface of at least some of the one or more conductors. The present invention further provides an apparatus for carrying out this method. | 01-27-2011 |
Maria Luisa Gallese, Via Bultrini IT
| Patent application number | Description | Published |
|---|---|---|
| 20100031096 | INTERNAL FAIL BIT OR BYTE COUNTER - Briefly, in accordance with one or more embodiments, an internal fail byte counter is disclosed. | 02-04-2010 |
Maria Luisa Gallese, Avezzano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100138623 | Memory Area Protection System and Methods - In one embodiment, a non-volatile memory device includes a plurality of protection bits denoting that an area of memory in the device must be protected from being erased or programmed. The memory device further includes a majority logic circuit for determining the logic state of the majority of the plurality of protection bits. Another embodiment includes a pattern generator for generating the logic levels to be stored in the plurality of protection bits. | 06-03-2010 |
Maria Luisa Kirgan, Irvine, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120016717 | SYSTEMS AND METHODS OF ENHANCING LEADS - A client transmits one or more lead records to a lead enhancement module that is configured to enhance the received lead records and return enhanced lead records to the client. The lead enhancement module may return a contactability score for each lead record, indicating a likelihood that the individual identified in the lead may be contacted using the contact information provided in the lead record and/or additional contract information located by the lead enhancement module. The lead enhancement module may also receive additional data items associated with leads from one or more data sources. Additionally, statistical models that may be customized for each client may be applied to information associated with lead records in order to determine one or more propensity scores for each of the lead records, where a propensity score indicates a likelihood that an individual will take a particular action, such as purchasing particular goods or services. | 01-19-2012 |
Maria Luisa Krauel US
| Patent application number | Description | Published |
|---|---|---|
| 20110196040 | Skin Penetration Enhancing Systems for Polar Drugs - The invention relates to pharmaceutical compositions and related methods for the topical administration of polar drugs. In a particular embodiment, the invention relates to a pharmaceutical composition comprising an active pharmaceutical agent that is a polar drug, such as potassium 2,5-dihydroxybenzenesulfonate, at least one occlusive agent, and at least one stabilizer. | 08-11-2011 |
Maria Luisa Krauel, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20120015912 | USE OF 2,5-DIHYDROXYBENZENE FOR THE TREATMENT OF OCULAR DISEASES - The present invention relates to the use of a compound of Formula (I | 01-19-2012 |
Maria Luisa Leon Diaz, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20120095064 | (PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS - A compound of Formula (I) | 04-19-2012 |
Maria Luisa Lucero De Pablo, Algorta ES
| Patent application number | Description | Published |
|---|---|---|
| 20100004285 | POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-al- pha alpha-DIMETHYL-BENZENEACETIC ACID - Crystalline form 1 4-[2-[4-[1 -(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]-ethyl]-αα-dimethyl-benzeneacetic acid of formula (I) is described, procedures for its preparation, pharmaceutical formulae containing crystalline form 1 and the use of crystalline form 1 to treat allergic reactions and pathological processes mediated by histamine in mammals such as man. | 01-07-2010 |
Maria Luisa Marín Martínez, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100266550 | MAMMALIAN MILK MICROORGANISMS, COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MASTITIS - The present invention relates to a novel approach to prevent or treat mastitis both in humans and animals through the use of mammal milk-derived microorganisms obtained from healthy hosts of the homologous species; to those new probiotic microorganisms obtained from milk able to reduce infectious mastitis and the method of screening used for their obtaining; to the use of these probiotic bacteria for the prophylaxis or treatment against mastitis and other diseases; and finally, to compositions comprising these compounds. | 10-21-2010 |
Maria Luisa Marín Martínez, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100266550 | MAMMALIAN MILK MICROORGANISMS, COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MASTITIS - The present invention relates to a novel approach to prevent or treat mastitis both in humans and animals through the use of mammal milk-derived microorganisms obtained from healthy hosts of the homologous species; to those new probiotic microorganisms obtained from milk able to reduce infectious mastitis and the method of screening used for their obtaining; to the use of these probiotic bacteria for the prophylaxis or treatment against mastitis and other diseases; and finally, to compositions comprising these compounds. | 10-21-2010 |
Maria Luisa Mas Rosique, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100093284 | Method and apparatus for collecting user activity in a telecommunications system - Method and apparatuses for collecting user activity information in a telecommunications system. A first telecommunications node ( | 04-15-2010 |
| 20100189017 | METHOD AND APPARATUSES FOR INFLUENCING THE INVOKING OF A SERVICE PROVIDED BY AN APPLICATION SERVER TO A USER EQUIPMENT - A server and method are described herein that can influence the invoking of a service provided by an application server to a user-user equipment. The server includes a database that stores a service profile for the user-user equipment, where the service profile has a number of filter criteria wherein at least one includes: (1) a first trigger point and at least one first service point trigger that specifies one or more conditions which when satisfied will be downloaded to and checked by a remote control function before a service is invoked for the user-user equipment; and (2) a second trigger point and at least one second service point trigger that specifies one or more conditions which are checked against internally stored data associated with the user-user equipment and need to be satisfied before the service profile with the filter criteria including the first trigger point and the at least one first service point trigger is downloaded to and checked by the remote control function to invoke the service for the user-user equipment. | 07-29-2010 |
Maria Luisa Navarro Rico, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090124686 | GSK-3 INHIBITORS - The invention relates to urea derivatives of formula (I) as inhibitors of glycogen synthase kinase 3β, GSK-3, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which GSK-3 is involved, such as Alzheimer's disease or non-insulin dependent diabetes mellitus. | 05-14-2009 |
| 20090192204 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I) for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 07-30-2009 |
| 20090221647 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 09-03-2009 |
Maria Luisa Nolli, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100310586 | IDIOTYPIC VACCINE - The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations. | 12-09-2010 |
| 20110123557 | ANTI-HMGA1 MONOCLONAL ANTIBODIES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE QUANTITATIVE DETERMINATION OF HMGA1 - This invention concerns a panel of monoclonal antibodies against the High Mobility Group A 1 protein (HMGA1) and a process for preparing them, as well as the use of said antibodies for the quantitative determination of HMGA1 in biological fluids or in protein Iy sates deriving from lymphocyte cells. This invention also concerns a diagnostic kit for assessing risk factors related to the expression of the HMGA1 proteins. | 05-26-2011 |
Maria Luisa No Sanchez, Leioa ES
| Patent application number | Description | Published |
|---|---|---|
| 20090123329 | Metal Matrix Material Based On Shape-Memory Alloy Powders, Production Method Thereof and Use of Same - The invention relates to a metal matrix material based on shape-memory alloy powders, to the production method thereof and to the use of same. More specifically, the invention relates to a metal matrix material which is characterised in that it is based on particles of shape-memory alloy powder, having a base of copper at a concentration of between 45 vol.-% and 70 vol.-% in relation to the total volume of the material, said powder particles being supported by a metal matrix. The invention also relates to a method of producing the aforementioned material and to the use of same for absorbing vibrations, particularly acoustic and mechanical vibrations. | 05-14-2009 |
Maria Luisa Novella Requena, Terrassa ES
| Patent application number | Description | Published |
|---|---|---|
| 20080219020 | Lighting Assembly with Safety and Signalling Functions for Motor Vehicles - Comprises in combination: at least one light source; a support plate for the light source, which is at least one; a protective cover that permits the light emitted by the light source to reach the outside; at least one wall which, in combination with the cover, forms a casing to hold the said light source, in which at least the said support plate has a black coloured surface facing the said cover; and in which the position of said light source, which is at least one, in relation to the casing, is such that it emits the light directly to the exterior. | 09-11-2008 |
Maria Luisa Paccagnella, Noank, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100028915 | CIRCULATING TUMOR CELL ASSAY - Methods for the detection, enumeration and analysis of circulating tumor cells expressing insulin-like growth factor-1 receptors (IGF-1R) are disclosed. These methods are useful for cancer screening and staging, development of treatment regimens, and for monitoring for treatment responses, cancer recurrence or the like. Test kits that facilitate the detection, enumeration and analysis of such circulating tumor cells are also provided. | 02-04-2010 |
Maria Luisa Rodríguez Buey, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20120017337 | GENES REGULATING PLANT BRANCHING, PROMOTORS, GENETIC CONSTRUCTS CONTAINING SAME AND USES THEREOF - The invention relates to genes coding for TCP family transcription factors and having a biological role in the development of axillary buds and branch growth. Furthermore, the invention relates to the promoters of the transcription of said genes, to the genetic constructs containing same and to the uses thereof, including the use of agents that modulate the expression of these genes in order to modify plant architecture. | 01-19-2012 |
Maria Luisa Sapino, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110264699 | METHOD AND SYSTEM FOR CONTENT CLASSIFICATION - A processing method for classification ( | 10-27-2011 |
Maria Luisa Sulis, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110118192 | METHODS AND COMPOSITIONS FOR TREATING T-CELL LEUKEMIA - The present invention relates to compositions and methods that may be used to diagnose and treat cancer, particularly T-cell leukemia. According to one preferred embodiment of the present invention, methods are provided for determining whether reducing or blocking NOTCH-1 activation will be effective to treat, prevent, or ameliorate the effects of a cancer in a patient, including T-cell leukemia, myeloleukemia, neuroblastoma, breast cancer, and ovarian cancer. The methods generally include determining if the patient harbors one or more mutations in a PTEN coding region. In particular, the methods may be used to determine whether reducing or blocking NOTCH-1 activation, with one or more γ-secretase inhibitors, will be effective to treat, prevent, or ameliorate the effects of a cancer in a patient. | 05-19-2011 |
Maria Luisa Ventresca, Los Teques VE
| Patent application number | Description | Published |
|---|---|---|
| 20110021387 | REVERSIBLE GELLING SYSTEM AND METHOD USING SAME DURING WELL TREATMENTS - An all-oil reversible gelling system includes a polymer, a crosslinker, a gel accelerator, and an oxidant, wherein temperature activates the crosslinker so as to cause the system to form a gel, and the oxidant subsequently decomposes the gel. This gel is designed to seal temporarily portions of oil-producing or water or gas injecting subterranean formations. | 01-27-2011 |
Maria Luisa Villahermosa Jaen, San Javier ES
| Patent application number | Description | Published |
|---|---|---|
| 20110070576 | VITRO DIAGNOSTIC KIT FOR IDENTIFICATION OF HUMAN PAPILLOMAVIRUS IN CLINICAL SAMPLES - A method and kit for detection and typing of HPV in a sample are described, as is a reaction vessel for use in the method. Universal HPV primers are used to amplify a sample by PCR; the amplified sample is then hybridised to an array of HPV type-specific probes to determine the HPV type. | 03-24-2011 |